A recent work showed that CRISPR-Cas9 mediated knockout of CHD7 in LN-229 GBM cells leads to decreased growth rate and invasion both in vitro and in orthotopic xenografts, ameliorating mice survival. Here, CHD7 is linked to glioblastoma.